Investing.com – Amgen (NASDAQ:) reported on Thursday third quarter that beat analysts’ forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.70 on revenue of $6.7B. Analysts polled by Investing.com anticipated EPS of $4.45 on revenue of $6.58B.
Amgen shares are up 18% from the beginning of the year, still down 3.27% from its 52 week high of $274.88 set on November 2.
Amgen shares gained 1.02% in after-hours trade following the report.
Amgen follows other major Healthcare sector earnings this month
Amgen’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Story Credit: investing.com